PHARMAGREEN BIOTECH INC. Debt Instrument, Convertible, Beneficial Conversion Feature
PHARMAGREEN BIOTECH INC. reported Debt Instrument, Convertible, Beneficial Conversion Feature of $32.48 thousand for the 12-month period ending 2018-09-30, per its 10-K filed 2019-12-30.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature · last filed 2019-12-30
- PHARMAGREEN BIOTECH INC. debt instrument, convertible, beneficial conversion feature for the quarter ending 2018-09-30 was $0.00.
- PHARMAGREEN BIOTECH INC. debt instrument, convertible, beneficial conversion feature for the quarter ending 2018-06-30 was $32.48K.
- PHARMAGREEN BIOTECH INC. debt instrument, convertible, beneficial conversion feature for fiscal 2018 was $32.48K.
| Period end | Debt Instrument, Convertible, Beneficial Conversion Feature 3 month | Debt Instrument, Convertible, Beneficial Conversion Feature 6 month | Debt Instrument, Convertible, Beneficial Conversion Feature 9 month | Debt Instrument, Convertible, Beneficial Conversion Feature 12 month |
|---|---|---|---|---|
| 2018-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-30 | $32.48K derived: sum of 2 quarters · filed 2019-12-30 | $32.48K 10-K · filed 2019-12-30 | |
| 2018-06-30 | $32.48K 10-Q · filed 2019-08-19 | $32.48K 10-Q · filed 2019-08-19 |